1,3,5-Tri-O-benzoyl-D-Ribofuranose CAS 22224-41-5 Purity ≥99.0% Clofarabine Yepakati Yakanyanya Kuchena Inoratidzwa Mufananidzo

1,3,5-Tri-O-benzoyl-D-Ribofuranose CAS 22224-41-5 Kuchena ≥99.0% Clofarabine Yepakati Yakanyanya Kuchena

Tsanangudzo Pfupi

Zita reKemikari: 1,3,5-Tri-O-benzoyl-D-Ribofuranose

CAS: 22224-41-5

Chitarisiko: White kana Off-White Powder

Kuchena: ≥99.0%

Pakati peClofarabine (CAS: 123318-82-1) mukurapa kweVana vane Acute Lymphoblastic Leukemia (ALL)

Inquiry: alvin@ruifuchem.com

Tumira email kwatiri

Product Detail

Product Tags

Tsanangudzo:

Commercial Supply Clofarabine Related Intermediates:
Clofarabine CAS: 123318-82-1
2-Deoxy-2-fluoro-1,3,5-tri-O-benzoyl-α-D-arabinofuranose CAS: 97614-43-2
β-D-Ribofuranose 1-Acetate 2,3,5-Tribenzoate CAS: 6974-32-9
1,3,5-Tri-O-benzoyl-D-Ribofuranose CAS: 22224-41-5
2,6-Dichloropurine CAS: 5451-40-1

Chemical Properties:

Chemical Name	1,3,5-Tri-O-benzoyl-D-Ribofuranose
Nhamba yeCAS	22224-41-5
Nhamba yeCAT	RF-PI223
Stock Status	MuStock, Kugadzirwa Kunokwira Kusvika Matani
Molecular Formula	C26H22O8
Molecular Weight	462.45
Melting Point	125.0-129.0℃(lit.)
Solubility	Insoluble muMvura
Brand	Ruifu Chemical

Zvinotsanangurwa:

Item	Zvinotsanangurwa
Chitarisiko	White kana Off-White Powder
Kuchena	≥99.0%
Kurasika paKuomesa	≤1.00%
Maximum Single Kusachena	≤0.50%
Zvose Zvisina Kuchena	≤1.00%
Heavy Metals	≤20ppm
Test Standard	Enterprise Standard
Usage	Pakati peClofarabine (CAS: 123318-82-1)

Package & Kuchengeta:

Package: Bhodhoro, Aluminium foil bag, Cardboard dhiramu, 25kg/Drum, kana zvinoenderana nezvinodiwa nemutengi.

Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza, mwando uye tumbuyu.

Zvakanakira:

FAQ:

Application:

1,3,5-Tri-O-benzoyl-D-Ribofuranose (CAS: 22224-41-5) chinhu chekutanga che nucleoside synthesis.Inogona kushandiswa sepakati peClofarabine (CAS: 123318-82-1).Clofarabine ibhuku repurine nucleoside anticancer drug rakatanga kugadzirwa neTop10 biopharmaceutical company yeUnited States-Genzyme Corporation nemazita ekutengesa ari "Clofarabine".Musi waZvita 28, 2004 iyo FDA yakashandisa kukurumidza-track kubvumidza Clofarabine kuti ishandiswe kuvana vane refractory kana relapsed acute lymphocytic leukemia.Clofarabine inosanganisa zvakanakira zveFludarabine neCladribine kuti inhibit zvese DNA polymerase uye RIbonucleic acid reductase.Parizvino ndiyo yega mushonga unokodzera kurapwa kweudiki leukemia.Zvidzidzo zvakaratidza kuti kugona kwayo kwekurapa kwakanyanya, uye huwandu hwekupindura hwevarwere vasina mhinduro kune maviri akajairwa chemotherapy ndeye 31%.Uye kushivirira kushivirira kwakanaka, hapana maitiro asina kunaka asingatarisirwi;Iyo ine zvingangoita yakakura-spectrum antitumor properties.